Psoriasis scalp hair loss is a common concern for people living with scalp psoriasis, a chronic inflammatory condition that causes raised, scaly plaques on the scalp. Although psoriasis does not permanently destroy hair follicles, the associated inflammation, persistent itching, and physical trauma from scratching can disrupt the hair growth cycle, leading to temporary shedding. Understanding why this happens, how to recognise the symptoms, and what treatments are available is essential for protecting scalp health and encouraging hair regrowth. This guide covers NHS-aligned diagnosis, treatment options, and practical self-care strategies.

How Scalp Psoriasis Can Contribute to Hair Loss

Scalp psoriasis causes temporary hair shedding primarily through follicular inflammation pushing hairs into the telogen (resting) phase, compounded by physical trauma from scratching; permanent hair loss is uncommon and regrowth usually follows effective treatment.

Not sure if this is normal? Chat with one of our pharmacists →

Scalp psoriasis is a chronic inflammatory skin condition that causes raised, scaly plaques to form on the scalp. While psoriasis itself does not directly destroy hair follicles, the associated inflammation, scratching, and certain treatments can disrupt the normal hair growth cycle, leading to temporary hair shedding — most commonly in the form of telogen effluvium (hair shedding secondary to scalp psoriasis and scratching) rather than a distinct diagnostic entity.

The mechanism behind this hair shedding is primarily linked to the inflammatory environment created by psoriasis. Persistent inflammation around the hair follicle can push hairs prematurely into the telogen (resting) phase of the growth cycle, resulting in increased shedding. This is not the same as permanent hair loss; in most cases, hair regrows once the underlying condition is adequately controlled.

Physical trauma to the scalp also plays a significant role. Vigorous scratching to relieve the intense itch associated with scalp psoriasis can cause mechanical damage to hair shafts and follicles, as can forcibly picking or removing thick scale. Additionally, thick, adherent scale — including a presentation known as pityriasis amiantacea, in which matted scale encases the hair shafts — can physically impede normal growth and cause temporary shedding.

Scarring alopecia is uncommon in psoriasis, and most hair loss associated with the condition is non-scarring and reversible. However, patients should seek prompt medical review if they notice features that may suggest scarring, such as persistent patchy hair loss that does not recover, or signs of secondary infection. Understanding this distinction is reassuring: with effective management and by minimising scratching and trauma, hair density can usually be preserved or restored.

Recognising the Symptoms of Scalp Psoriasis

Scalp psoriasis typically presents as raised, salmon-pink plaques with silvery-white scale, intense itching, and temporary hair thinning; red flags such as broken hairs, a boggy scalp swelling, or posterior cervical lymphadenopathy warrant prompt GP assessment.

Scalp psoriasis can range from mild, barely noticeable patches to severe involvement covering the entire scalp and extending beyond the hairline onto the forehead, back of the neck, or around the ears. Recognising the characteristic symptoms early can help patients seek timely treatment and reduce the risk of complications such as hair thinning.

The most common symptoms include:

• Raised, reddish or salmon-pink plaques covered with silvery-white scales

• Intense itching, which can be persistent and disruptive to daily life

• Dry scalp that may crack or bleed when scales are removed

• Burning or soreness on the affected areas

• Temporary hair thinning or patchy hair loss, particularly in areas of heavy scaling or repeated scratching

• Flaking that may resemble dandruff but is typically thicker and more adherent

It is worth distinguishing scalp psoriasis from other common scalp conditions. Seborrhoeic dermatitis also causes flaking and redness but tends to produce greasier, yellowish scales and is associated with a yeast called Malassezia rather than an autoimmune process. Tinea capitis (scalp ringworm), caused by a fungal infection, can also produce scaling and hair loss and requires antifungal treatment — it should not be confused with psoriasis.

Red flags that warrant prompt GP assessment — particularly in children — include broken hairs or 'black dots' at the scalp surface, a boggy, painful swelling on the scalp (kerion), posterior cervical lymphadenopathy, or rapid patchy hair loss. These features may suggest tinea capitis or a kerion, which require mycological testing and urgent antifungal treatment. Signs of secondary bacterial infection — such as oozing, crusting, or pustules — also warrant prompt medical review.

In some individuals, scalp psoriasis may be the first or only manifestation of psoriasis, with no plaques elsewhere on the body. Awareness of these symptoms is therefore important, as the condition is sometimes mistaken for severe dandruff and left untreated for prolonged periods, increasing the risk of hair loss.

NHS Diagnosis and When to See a GP or Dermatologist

Scalp psoriasis is diagnosed clinically by a GP or dermatologist; you should seek review if scaling persists despite over-the-counter treatments, hair thinning occurs, or symptoms affect sleep, work, or mental wellbeing.

Scalp psoriasis is typically diagnosed clinically, meaning a GP or dermatologist can usually identify it through a physical examination of the scalp and skin without the need for laboratory tests. The characteristic appearance of well-demarcated, scaly plaques — often with a silvery surface — alongside a personal or family history of psoriasis, is usually sufficient for diagnosis.

You should consider booking an appointment with your GP if you notice:

• Persistent scalp scaling that does not respond to over-the-counter dandruff shampoos

• Significant itching, soreness, or bleeding from the scalp

• Noticeable hair thinning or patchy hair loss associated with scalp symptoms

• Plaques spreading beyond the hairline onto the face or neck

• Signs of secondary infection (oozing, crusting, pustules)

• Symptoms that are affecting your sleep, work, or mental wellbeing

Your GP may refer you to a consultant dermatologist if the diagnosis is uncertain, if the condition is severe or widespread, or if initial treatments have not provided adequate relief. Referral should also be considered if there are features suggesting scarring alopecia, suspected tinea capitis or kerion, or rapidly progressive disease. In some cases, a scalp biopsy may be performed to confirm the diagnosis and rule out other conditions such as lichen planopilaris, which can cause scarring alopecia.

If you experience joint pain, stiffness, swelling, enthesitis (tendon or ligament pain at bony attachments), or dactylitis (sausage-like swelling of a finger or toe) alongside your skin symptoms, report this to your GP promptly. These features may indicate psoriatic arthritis, and referral to a rheumatologist may be appropriate.

NICE guidance on psoriasis (CG153: Psoriasis: assessment and management) recommends that healthcare professionals routinely assess the physical and psychological impact of the condition, considering validated tools such as the Dermatology Life Quality Index (DLQI) where appropriate. Hair loss, even when temporary, can cause significant distress, and this should be acknowledged and addressed as part of a holistic management plan. Patients should not feel that hair thinning is a trivial concern — it is a legitimate reason to seek medical review.

Treatment Options for Scalp Psoriasis and Hair Regrowth

NICE recommends a stepwise approach starting with potent topical corticosteroids and vitamin D analogues, escalating to systemic or biological therapies for moderate-to-severe disease; hair regrowth typically follows once inflammation is controlled.

Effective treatment of scalp psoriasis is the most important step in allowing hair to regrow. NICE (CG153) recommends a stepwise approach, beginning with topical therapies and escalating to systemic or biological treatments for moderate-to-severe disease.

First-line topical treatments include:

• Potent topical corticosteroids (e.g., betamethasone valerate) — these reduce inflammation and are available as scalp applications, foams, or shampoos to minimise cosmetic disruption. Potent topical corticosteroids are typically used for a short initial course (usually up to four weeks), then intermittently as directed by a clinician; prolonged continuous use should be avoided. Follow the prescriber's instructions and the product's Summary of Product Characteristics (SmPC).

• Vitamin D analogues (e.g., calcipotriol) — these slow the rapid skin cell turnover characteristic of psoriasis. Combination products containing both a corticosteroid and calcipotriol are widely used and available in scalp-appropriate formulations.

• Coal tar preparations — available in shampoo form, these have anti-inflammatory and antiproliferative properties and can help soften and lift scale.

• Salicylic acid — used as a keratolytic to remove thick scale before other treatments are applied, improving their penetration and efficacy. Salicylic acid should not be applied over large areas of the body, particularly in pregnancy.

For moderate-to-severe scalp psoriasis that does not respond to topical therapy, phototherapy (narrowband UVB) or systemic treatments may be considered. NICE-approved systemic options include methotrexate, ciclosporin, acitretin, apremilast, and dimethyl fumarate. Escalation to systemic therapy follows NICE eligibility criteria, which take into account disease severity (e.g., PASI score), impact on quality of life (e.g., DLQI >10), and involvement of special areas such as the scalp causing significant functional or psychological impact.

Biological therapies — including anti-TNF agents (e.g., adalimumab), IL-17 inhibitors (e.g., secukinumab, ixekizumab), and IL-23 inhibitors (e.g., guselkumab, risankizumab) — are approved by NICE for eligible patients with refractory moderate-to-severe disease. Eligibility is defined by NICE Technology Appraisals; a dermatologist will assess suitability.

Important safety notes:

• Several systemic treatments, including methotrexate and acitretin, are contraindicated in pregnancy and breastfeeding. Women of childbearing potential must use effective contraception and discuss their treatment plan with their clinician before conception.

• If you experience a suspected side effect from any treatment, report it to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Once inflammation is controlled, hair regrowth typically occurs gradually over several months, though the timeline varies between individuals and depends on how well inflammation is controlled and how much scalp trauma has been minimised. Consistent adherence to treatment is essential for sustained results.

Managing Scalp Psoriasis at Home Safely

Safe home management includes avoiding scratching, using gentle fragrance-free hair products, softening scale with oils before treatment, and identifying personal triggers; emollients and hair oils increase fire risk and should be kept away from naked flames.

Alongside prescribed treatments, a number of safe self-care strategies can help manage scalp psoriasis, reduce flare frequency, and protect hair health. These measures complement — but do not replace — medical treatment.

Practical home management tips include:

• Avoid scratching — although the itch can be intense, scratching worsens inflammation, damages hair follicles, and risks introducing infection. Keeping nails short and applying a cool compress can help relieve itch without causing harm.

• Use gentle hair care products — choose mild, fragrance-free shampoos and avoid harsh chemical treatments such as bleaching, perming, or relaxing, which can aggravate an already sensitive scalp.

• Apply treatments correctly — scalp applications should be massaged gently into the scalp (not the hair shaft) and left on for the recommended duration before washing out. Parting the hair in sections can help ensure even coverage.

• Soften scale before treatment — applying coconut oil, olive oil, or a prescribed emollient overnight under a shower cap can help loosen thick scale, making it easier to remove gently with a soft brush or comb. Avoid forcibly picking or vigorously brushing scale, as this can cause hair breakage. Stop any home measure that causes increased irritation and consult your GP if irritation or signs of infection develop.

• Emollient and oil flammability — emollients and hair oils can soak into fabric and increase fire risk. Keep treated areas away from naked flames, cigarettes, and other ignition sources. This is an MHRA safety recommendation.

• Manage known triggers — common triggers include stress, infections (particularly streptococcal throat infections), certain medicines (e.g., beta-blockers, lithium, antimalarials such as hydroxychloroquine), and alcohol. Always inform your prescriber of any new medicines, as some can trigger or worsen psoriasis. Identifying and minimising personal triggers can reduce flare frequency.

Over-the-counter coal tar shampoos can be useful for mild symptoms but should be used as directed. If symptoms worsen or do not improve within four weeks of self-treatment, medical advice should be sought promptly.

Long-Term Outlook and Preventing Flare-Ups

The long-term outlook is generally positive, with most patients achieving full hair regrowth once psoriasis is controlled; proactive management, regular follow-up, and trigger avoidance are key to minimising flare frequency and preserving hair density.

The long-term outlook for scalp psoriasis and associated hair loss is generally positive. For the majority of patients, hair regrows fully once the condition is brought under control, and permanent hair loss is uncommon. However, psoriasis is a chronic, relapsing-remitting condition, meaning flare-ups are likely over a person's lifetime. Proactive management is therefore key to preserving both scalp health and hair density in the long term.

Regular follow-up with a GP or dermatologist is important for monitoring treatment response, adjusting therapy as needed, and screening for associated conditions. Psoriasis is associated with a number of comorbidities, including psoriatic arthritis (which affects up to 30% of people with psoriasis), cardiovascular disease, metabolic syndrome, and mental health conditions such as depression and anxiety. Patients experiencing joint pain, stiffness, swelling, enthesitis, or dactylitis alongside their skin symptoms should report this to their GP promptly, as referral to a rheumatologist may be appropriate. Regular cardiovascular risk assessment and lifestyle measures — including weight management, smoking cessation, and physical activity — are also recommended as part of holistic care.

From a psychological perspective, the visible nature of scalp psoriasis and the distress caused by hair thinning should not be underestimated. Patients are encouraged to access support through organisations such as the Psoriasis Association (psoriasis-association.org.uk) and the British Association of Dermatologists (bad.org.uk), both of which provide evidence-based patient information, peer support, and advocacy resources. The NHS psoriasis pages (nhs.uk) also offer reliable guidance on symptoms, treatment, and living with the condition.

In terms of prevention, while psoriasis cannot be cured, the following strategies can help reduce the frequency and severity of flare-ups:

• Maintaining a consistent treatment regimen, even during periods of remission

• Managing stress through mindfulness, exercise, or psychological support

• Avoiding known personal triggers and discussing any new medicines with a prescriber

• Attending regular skin reviews to catch early signs of relapse before they escalate

With the right combination of medical treatment, self-care, and lifestyle management, most people with scalp psoriasis can achieve good disease control and maintain healthy hair growth over the long term.

Frequently Asked Questions